Lunesta, Xoponex Prices Raised By 9%
This article was originally published in The Pink Sheet Daily
Executive Summary
Sepracor has not seen a negative impact on inventory from a recent price increase, the company reported.
You may also be interested in...
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Hospira’s Mayne Event: Acquisition Strengthens Oncology Portfolio
Merger will create the leading generic injectable pharmaceutical company in the world.
Sharer Replaces Dolan As PhRMA Chairman
Amgen CEO gets early promotion.